No buy transactions available for this period
Pfizer INC filed its 13F report for Q2 2026 on August 13, 2026. The portfolio totaled 170.37 M reflecting a -28.65% change from the prior quarter, spanning 17 assets. The top 10 holdings comprised 95.8% of the portfolio, with Financials as the largest sector allocation. Quarterly activity included 0 new positions and 1 complete exits.
Items:
Total Value:
| Issuer Name | Class | Value | Shares | Option Type |
|---|
Pfizer submitted their Form 13F-HR for the Q2 2026 period on 08/13/2026. This was the only submission for the quarter.
In the Q2 2026 filing, Pfizer reported a managed portfolio value of 170.37 M, consisting of 20 individual positions.
This page displays the raw filing documents. To see which stocks Pfizer bought or sold during Q2 2026, please visit Pfizer's Portfolio Analysis page.